Kindstar Globalgene Technology, Inc.
Status: Publicly traded
Direct answer
Kindstar Globalgene Technology, Inc. is publicly traded on HKSE under the ticker 9960.HK.
Kindstar Global (Beijing) Technology, Inc. is a prominent provider of highly specialized diagnostic services to healthcare institutions across China. Beyond just diagnostics, the company extends its expertise to support medical research, clinical drug trials, and translational medicine initiatives for a diverse client base, including individual practitioners, research organizations, various hospital types, and...
Can you invest in Kindstar Globalgene Technology, Inc.?
Yes. Kindstar Globalgene Technology, Inc. trades publicly on HKSE as 9960.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Kindstar Globalgene Technology, Inc.
Detailed equity research is provided by MarketSnap.